Weiwei Mu

机构：Shandong University, Ghent University Hospital · ORCID：0000-0003-0296-798X

发表论文 58 篇 · 总被引 1635 次 · h-index 23

代表论文

• Temperature sensitive liposome based cancer nanomedicine enables tumour lymph node immune microenvironment remodelling (2023 · Nature Communications · 被引 79)
• Delivery Strategy to Enhance the Therapeutic Efficacy of Liver Fibrosis via Nanoparticle Drug Delivery Systems (2024 · ACS Nano · 被引 68)
• Transforming Cancer-Associated Fibroblast Barrier into Drug Depots to Boost Chemo-Immunotherapy in “Shooting Fish in a Barrel” Pattern (2023 · ACS Nano · 被引 40)
• Glypican-3-targeted macrophages delivering drug-loaded exosomes offer efficient cytotherapy in mouse models of solid tumours (2024 · Nature Communications · 被引 39)
• Artificial Assembled Macrophage Co-Deliver Black Phosphorus Quantum Dot and CDK4/6 Inhibitor for Colorectal Cancer Triple-Therapy (2022 · ACS Applied Materials & Interfaces · 被引 27)
• Cell Membrane Biomimetic Nano-Delivery Systems for Cancer Therapy (2023 · Pharmaceutics · 被引 25)